A team, led by Australian researchers, has found injections of an inhibitor reduced the proliferation of pre-cancerous cells in BRCA1 breast tissue in mice and three Melbourne women carrying the gene mutation.
The drug is currently used to treat osteoporosis and will soon be tested in human clinical trials.
If proven right, it could allow women…
